文献速递乳房整形与再造创面修复

预防性局部抗生素用于组织扩张器(PLATE)改善乳房再造结局

Prophylactic Local Antibiotics for Tissue Expansion (PLATE) Improve Breast Reconstruction Outcomes.
PubMed 文献 · Plast Reconstr Surg · 2024-10-18

多机构回顾性研究比较组织扩张器乳房再造术中放置妥布霉素-万古霉素聚甲基丙烯酸甲酯板(PLATE)与历史对照的感染预防效果,PLATE组总体并发症和感染率均显著低于对照组,且不增加局部或全身并发症。

要点

  • PLATE组总体并发症13.1% vs 对照组21.9%(P<0.01)。
  • PLATE组感染4.8% vs 对照组12.6%(P<0.01)。
  • 多变量回归显示PLATE与任何并发症(OR 0.53;95%CI 0.3-0.93)和感染(OR 0.22;95%CI 0.08-0.50)几率降低相关。

核心结论

  • 组织扩张器置入术中预防性使用术中制作的PLATE与感染显著减少相关,且不增加局部或全身并发症。
  • 作者认为这一可重复的工具可能在所有异体乳房再造中具有很高价值。

研究设计与样本

  • 多机构回顾性研究,2021年3家机构的外科医生开始独立提供PLATE用于初次组织扩张器乳房再造。
  • 经各机构独立伦理审查批准后,回顾性收集PLATE受试者和干预前队列的数据,样本量相当。
  • 受试者随访7个月或至二期取出,主要结局为需要再入院/再手术的并发症,汇总队列间进行比较,分析包括逻辑回归建模和Kaplan-Meier生存分析。
  • 汇总样本包括183例干预受试者(292侧乳房)和183例对照(301侧乳房),随访均为5±2个月。

主要发现

  • PLATE组总体并发症发生率13.1% vs 对照组21.9%(P<0.01),PLATE组显著更低。
  • PLATE组感染发生率4.8% vs 对照组12.6%(P<0.01),PLATE组显著更低。
  • 组织坏死、血清肿或其他并发症发生率两组无差异(P>0.05)。
  • 多变量回归中,干预与任何并发症几率显著降低相关(OR 0.53;95%CI 0.3-0.93),与感染几率显著降低相关(OR 0.22;95%CI 0.08-0.50)。
  • Kaplan-Meier曲线显示并发症和感染随时间显著降低(P<0.01),抗生素洗脱剂消散期间未见明显反弹。

临床怎么用

  • 作者认为组织扩张器置入术中预防性使用术中制作的PLATE与感染显著减少相关,且不增加局部或全身并发症,这一可重复的工具可能在所有异体乳房再造中具有很高价值。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Infection following tissue expander (TE) breast reconstruction is frequent and impactful. Preliminary reports demonstrate value of local antibiotic delivery for implant salvage and prophylactic potential. This article is a multiinstitutional retrospective study using surgeon-crafted tobramycin-vancomycin polymethyl methacrylate plates (prophylactic local antibiotics for tissue expansion [PLATE]) during TE implantation for infection prophylaxis. The authors hypothesized that the intervention would be associated with fewer infections compared with historical practice. METHODS: In 2021, surgeons at 3 institutions began independently offering PLATE for primary TE breast reconstructions. After independent institutional review board approvals, data were retrospectively collected for PLATE subjects and preintervention cohorts of equivalent sizes. Subjects were followed up for 7 months, or to second-stage removal. The primary outcome-complication requiring readmission/reoperation-was compared between aggregated cohorts. Analysis included logistic modeling and Kaplan-Meyer survival. RESULTS: The aggregate sample included 183 intervention subjects (292 breasts) and 183 controls (301 breasts), each with 5 ± 2-month follow-up. Overall, complications were significantly less frequent with PLATE (13.1% versus 21.9%; P < 0.01). This was driven by significantly fewer infections (4.8% versus 12.6%; P < 0.01) with no difference in rates of tissue necrosis, seroma, or other complications ( P > 0.05). In multivariable regression, the intervention was associated with significantly reduced odds of any complication (OR, 0.53; 95% CI, 0.3 to 0.93) and infection (OR, 0.22; 95% CI, 0.08 to 0.50). Kaplan-Meyer curves demonstrated significant longitudinal reduction in complication and infection ( P < 0.01) without notable rebound throughout dissipation of the antibiotic eluent. CONCLUSIONS: Prophylactic use of intraoperatively crafted PLATE during TE implantation was associated with significant infection reduction without increase in local or systemic complications. This reproducible tool may be highly valuable in alloplastic breast reconstruction. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, III.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Clark RC, Cevallos P, Dadpey B, et al. Prophylactic Local Antibiotics for Tissue Expansion (PLATE) Improve Breast Reconstruction Outcomes. Plast Reconstr Surg. 2024. PMID: 39451154. doi:10.1097/PRS.0000000000011832

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。